Gene Therapy AMT-130 in Huntington Disease, NDA Submitted for Troriluzole in Spinocerebellar Ataxia, FDA Clears Alzheimer Assays
Neurology News Network for the week ending July 1, 2023. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — June 30, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending June 30, 2023.
This Week on NeurologyLive® — June 26, 2023
Here's some of what is coming soon to NeurologyLive® this week.
CNM-Au8 Reduces Neurofilament Light, Candesartan Benefits Headache, Ketamine Shows Potential in Migraine
Neurology News Network for the week ending June 24, 2023. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — June 23, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending June 23, 2023.
This Week on NeurologyLive® — June 19, 2023
Phase 3 LAVENDER Trial Results Published, Protective and Risk Factors of Insomnia, Lecanemab Gets Positive FDA AdComm Review
Neurology News Network for the week ending June 17, 2023. [WATCH TIME: 3 minutes]
This Week on NeurologyLive® — June 12, 2023
BIIB122 Discontinued in LRRK2 Parkinson Disease, Pimavanserin and PTSD-Associated Insomnia, Obstructive Sleep Apnea Following VNS
Neurology News Network for the week ending June 10, 2023. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — June 9, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending June 9, 2023.
This Week on NeurologyLive® — June 5, 2023
CMS Adds Coverage for Antiamyloid Therapies, NDA for Migraine Agent Accepted, INTUNE Study Ahead of Schedule
Neurology News Network for the week ending June 2, 2023. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — June 2, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending June 2, 2023.
This Week on NeurologyLive® — May 29, 2023
Wave Discontinues ALS Agent WVE-004, FDA Pushes Back Decision on SRP-9001, Asundexian Receives Fast Track Designation
Neurology News Network for the week ending May 27, 2023. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — May 26, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending May 26, 2023.
This Week on NeurologyLive® — May 22, 2023
Treg Treatment Sustains Cognition in AD, FDA Approves Spinal Cord Stimulation Systems, Soticlestat Reduces Seizures in CDD
Neurology News Network for the week ending May 20, 2023. [WATCH TIME: 4 minutes]
NeurologyLive® Friday 5 — May 19, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending May 19, 2023.
This Week on NeurologyLive® — May 15, 2023
CVD Risk in Epilepsy Increases Dementia Risk, Teriflunomide in RIS, FDA Clears Dry-Sensor EEG Headset
Neurology News Network for the week ending May 13, 2023. [WATCH TIME: 4 minutes]
NeurologyLive® Friday 5 — May 12, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending May 12, 2023.
This Week on NeurologyLive® — May 8, 2023
Zavegepant Effective Regardless of Aura Status, FDA Approves Extended-Release Sodium Oxybate, Mediterranean Diet Adherence Improves MS Cognition
Neurology News Network for the week ending May 6, 2023. [WATCH TIME: 4 minutes]
NeurologyLive® Friday 5 — May 5, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending May 5, 2023.
This Week on NeurologyLive® — May 1, 2023
Atogepant's Impact on Chronic Migraine, LD/CD Intra-Oral Pump Improves ON Time, Ravulizumab Effective in NMOSD Subgroups
Neurology News Network for the week ending April 30, 2023. [WATCH TIME: 4 minutes]
NeurologyLive® Friday 5 — April 28, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending April 28, 2023.
This Week on NeurologyLive® — April 24, 2023
DEA Rules Fenfluramine No Longer Controlled Substance, Positive FDA ADComm Meeting of Brexpiprazole, Antiamyloid Drugs Accelerate Brain Atrophy
Neurology News Network for the week ending April 22, 2023. [WATCH TIME: 4 minutes]